Skip to content

Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis

Characterization of Cutaneous Microbiota and Evaluation of the Antimicrobial Peptides Roles in the Psoriasis Etiopathogenesis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03475914
Acronym
MICROBIOTA
Enrollment
24
Registered
2018-03-23
Start date
2016-10-13
Completion date
2017-11-21
Last updated
2018-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Keywords

Psoriasis Guttate, Psoriasis vulgaris

Brief summary

The skin harbors a complex and dynamic microbiota constituted by numerous microorganisms that live in symbiosis with the host. The specific etiology of psoriasis is still not-well understood; nonetheless several studies highlighted that that the skin microbiota could have a pivotal role in the maintenance and/or progression of the disease, acting as microbial predictor of psoriasis however. The aim of the present study was to characterize the microbiota of cutaneous biopsies associated to guttate and vulgaris psoriasis, both considering lesion and healthy skin belonging to the same psoriatic subject.

Detailed description

Twelve individuals with guttate psoriasis and 12 individuals with vulgaris psoriasis have been enrolled at Dermatological Unit of IRCCS Galeazzi Institute, Milan. Patients selected for the psoriasis vulgaris group had a course of disease stable for at least 1 month before collection. The second group presented guttate psoriasis, defined as eruptive, that is characterized by a rapid appearance and worsening of the clinical presentation within the month preceding the visit. From each participant, a punch was used to obtain a cutaneous sample from both a lesion and healthy skin area of 2 mm2 belonging to the left gluteus, for a total of 48 biological samples. Participants were selected and included in the study according to the following criteria: i) over 18 years of age; ii) use of a free-preservatives soap with moisturizing function; iii) no use of probiotics; iv) no use of antibiotics; v) no treatment with corticosteroids, biological drugs, methotrexate or retinoids in the month prior the sampling; vi) no use of topical corticosteroids, vitamin D derivatives or phototherapy; vi) no chronic or systemic infections; vii) no cutaneous acute infections; viii) no allergy to pollen, food and drugs ix) no pets. Informed consent was obtained from all subjects. A metagenomics approach, performed by the use of Ion torrent Personal machine, were used to investigate the bacterial composition of the skin microbiota associated to each samples collected. After sequencing, the data analysis were focused on the bacterial biodiversity and microbial networks existing in the skin microbiota to evaluate a hypothetical role of bacteria in the complex pathophysiological mechanisms involved in psoriasis.

Interventions

None listed

Sponsors

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* over 18 years of age; * use of a free-preservatives soap with moisturizing function, applied once a day;pets.

Exclusion criteria

* no use of probiotics in the month prior the sampling; * no use of antibiotics in the month prior the sampling; * no treatment with corticosteroids, biological drugs, methotrexate or retinoids in the month prior the sampling; * no use of topical corticosteroids, vitamin D derivatives or phototherapy in the month prior the sampling; * no chronic or systemic infections; * no cutaneous acute infections during sampling; * no allergy to pollen, food and drugs * no pets.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the Psoriasis Area and Severity Index (PASI)1 yearIt is a measurement of psoriasis severity .

Secondary

MeasureTime frameDescription
Chao's index1 yearIt is a measure of bacterial biodiversity
Microbial abundance1 yearIt is a measure of bacterial amount
Spearman's correlation1 yearIt a measure of the bacterial interactions
Shannon's indexAt the beginning of the studyIt is a measure of bacterial biodiversity
Simpson's index1 yearIt is a measure of bacterial biodiversity

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026